Alector, Inc. ( ALEC) - Key Metrics
ALEC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.21 | -$0.31 | -$0.31 |
| 2026Q1 | $0.01 | -$0.21 | -$0.45 | -$0.45 |
| 2025Q4 | $0.06 | -$0.36 | -$0.40 | -$0.40 |
| 2025Q3 | $0.03 | -$0.34 | -$0.32 | -$0.32 |
| 2025Q2 | $0.08 | -$0.30 | -$0.49 | -$0.49 |
ALEC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.39 |
| 2026Q1 | 0% | -2.56 |
| 2025Q4 | 0% | -1.15 |
| 2025Q3 | 0% | -2.18 |
| 2025Q2 | 0% | -1.17 |
ALEC
Price: $1.96
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 209662
Market Capitalization: 233.4 million